Developement and Validation of the Health Behavior Questionnaire Towards Deprescribing (HBQtD)

Psychological Clinical Trial

— HBQtD  

Official title:

Development and Validation of a Health Behaviour Theory-based Questionnaire to Explore the Willingness of Older Adults and Informal Caregivers to Deprescribe

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT06212713
• Other study ID #: DEPRESCRIBE
• Status: Recruiting
• Start date: October 1, 2023
• Est. completion date: October 2024

Study information

• Verified date: January 2024
• Source: Université Catholique de Louvain
• Contact: Stephan Van den Broucke, PhD
• Phone: 003210479046
• Email: stephan.vandenbroucke[@]uclouvain.be
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The goal of this observational study is to: 1. develop and validate a health behavior theory-based questionnaire to examine the older adults' and informal caregivers' determinants of deprescribing behavior 2. assess the psychometric properties of this new instrument 3. analyze the moderating influence of health literacy and locus of control on the effect of the determinants on deprescribing intention or behavior. Participants will be involved in the validating process by completing the questionnaire to be validated, as well as the HLS19_Q12 for health literacy and the MHLC questionnaire for locus of control.

Description:

BIBLIOGRAPHIC REFERENCES Prescribing medication is an essential dimension in the care of the older adults (i.e. people aged 60 or 65 and over). However, the ageing process leads to physiological changes that can increase the risk of adverse drug events, and inappropriate polypharmacy can contribute to drug-drug interactions, lower medication adherence, significant costs to both the patient and the healthcare system, and also reduce people's ability to perform activities of daily living. Therefore, it is important thinking about deprescription, defined by Reeve et al. (2022) as "a planned/ supervised process of dose reduction or the stopping of medicines that may be causing harm or conferring no additional benefit". As implementation deprescribing requires a complexes changes to established patters of behaviors, understanding the cognitive mechanisms underlying patient's and caregiver's behavior with respect to deprescribing, seems essential to improve the collaborative work between the patient, or even the caregivers, and the health professionals, to achieve the best health outcomes for the patient. In reality, health behavior theories provides a series of concepts deriving from social, cognitive and motivational psychology, that can be useful in understanding why people behave in certain ways in relation to their health. Screening Tools The patients' attitudes towards deprescribing (PATD) questionnaire, and its revised version questionnaire (rPATD), and Beliefs about Medicines Questionnaire (specific section) (BMQ-Specific) are 2 instruments widely used. However, this questionnaires don't consider critical domains that can be relevant to deprescribing, such as self-efficacy beliefs, outcome expectations, subjective norms, health goals, environmental barriers and enablers, among others. Hypothesis The investigators hypothesise that some of the gaps in existing tools will be filled by using health behaviour concepts in the development of an assessment tool. STUDY DESIGN AND METHODOLOGY APPLIED Type of study: Questionnaire development and validation - older adult and informal caregiver version Study configuration The initial questionnaire was developed considering the results of a previous systematic review (article currently being written), which was intended to identify (concepts included in) behavioral health theories (HBTs) that explain older adults' and informal caregivers' deprescribing intention and/or their actual deprescribing behavior, as well as the rPATD questionnaire and BMQ questionnaire. The initial version for informal caregivers was developed by modifying the wording of the items, in the version for the older adults, adapting them for informal caregivers. Another two questionnaires will be used in this study: one that measure health literacy (HLS19_Q12) and another one that assess the locus of control (Multidimensional Health Locus of control scale, MHLC). The development and validation of the questionnaire comprise 4 main steps: 1. Item Development 2. Preliminary pilot testing 1. Colleagues questionnaire feedback 2. "Cognitive pre-test" performed with older adults and informal caregivers to check the linguistic and analytical construction of the items, 3. First round with healthcare professionals and second round with older adults and informal carers for a self-administered questionnaire and focus group. 3. Pre-test of the questionnaire - older adult and informal caregiver version 4. Validation of the questionnaire - older adult and informal carer versions, using exploratory factor analysis Strategies for recruiting participants To recruit participants, several organisations and institutions will be contacted. Data Management Responsibilities The two questionnaire versions will be either a paper version for self-administration and an electronic version available online. DISSEMINATION OF RESULTS AND PUBLICATION POLICY The progress and results of this study will be discussed with the Di-Prescribe research team. At the end of the study, a scientific publication will be written by the co-investigator (Sara Alves Jorge) under the supervision of the sponsor representative and Prof Van den Broucke. A paper will also be written for publication in a peer-journal. Acknowledgements will be made to all those who will make this work possible, including healthcare professionals, the different institutions and organizations that will be contacted, as well as the older adults and informal caregivers who will take part in the study. In addition, some people who will be indirectly involved, in particular by giving support and guidance, will also be recognized.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 600
• Est. completion date: October 2024
• Est. primary completion date: May 2024
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

Older adults

• Age 60 years or older;
• Taking at least 5 medications daily;
• Having at least one chronic condition. Informal caregivers
• They self-identified as a caregiver (defined as having any role in a family member or friend's management of health and/ or medication management) of an older adult who has 60 years old or older, that are taking at least 5 medications daily;
• The care recipient lived in the community (at home with or without the caregiver) or in a NH. Exclusion Criteria: Older adults
• Suffering from psychiatric trouble;
• Past or present drug or alcohol dependency;
• Having a terminal illness;
• Inability to complete a written questionnaire in French due to a functional or cognitive impairment;
• Inability to understand and express oneself in French. Informal cariegivers
• Caregiver age under 18 years old;
• Caregivers who are paid for the care they provide;
• Caregiver inability to give consent and complete a written questionnaire in French;
• Caregiver inability to understand and speak in French.

Related Conditions & MeSH terms

• Psychological

Intervention

Other:
• Questionnaire administration
Questionnaire administration - version older adults and informal caregivers

Locations

Country	Name	City	State
Belgium	UCLouvain	Louvain-la-Neuve

Sponsors (1)

Lead Sponsor	Collaborator
Université Catholique de Louvain

Country where clinical trial is conducted

Belgium, 

References & Publications (59)

Abouzaid, S., Willemse, E., Remmen, R., Schmitz, O., Macq, J., Declercq, A., Arnaut, C., Forest, M., Denis, A., Vinck, I., Defourny, N., & Farfan-Portet, M. (s. d.). SUPPORT FOR INFORMAL CAREGIVERS - AN EXPLORATORY ANALYSIS.

Aithal, A., & Aithal, P. S. (2020). Development and Validation of Survey Questionnaire & Experimental Data - A Systematical Review-based Statistical Approach (SSRN Scholarly Paper No 3724105). https://doi.org/10.2139/ssrn.3724105

Ajzen, I. (1991). The Theory of Planned Behavior.

Ajzen, I., & Madden, T. J. (1986). Prediction of goal-directed behavior : Attitudes, intentions, and perceived behavioral control. Journal of Experimental Social Psychology, 22(5), 453-474. https://doi.org/10.1016/0022-1031(86)90045-4

Bandura A. Health promotion by social cognitive means. Health Educ Behav. 2004 Apr;31(2):143-64. doi: 10.1177/1090198104263660. — View Citation

Baumgartner AD, Clark CM, LaValley SA, Monte SV, Wahler RG Jr, Singh R. Interventions to deprescribe potentially inappropriate medications in the elderly: Lost in translation? J Clin Pharm Ther. 2020 Jun;45(3):453-461. doi: 10.1111/jcpt.13103. Epub 2019 Dec 24. — View Citation

Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med. 1997 Jul 28;157(14):1531-6. — View Citation

Chock YL, Wee YL, Gan SL, Teoh KW, Ng KY, Lee SWH. How Willing Are Patients or Their Caregivers to Deprescribe: a Systematic Review and Meta-analysis. J Gen Intern Med. 2021 Dec;36(12):3830-3840. doi: 10.1007/s11606-021-06965-5. Epub 2021 Jun 25. — View Citation

Clark LA, Watson D. Constructing validity: New developments in creating objective measuring instruments. Psychol Assess. 2019 Dec;31(12):1412-1427. doi: 10.1037/pas0000626. Epub 2019 Mar 21. — View Citation

Doval E, Viladrich C, Angulo-Brunet A. Coefficient Alpha: The Resistance of a Classic. Psicothema. 2023 Feb;35(1):5-20. doi: 10.7334/psicothema2022.321. — View Citation

Dunn TJ, Baguley T, Brunsden V. From alpha to omega: a practical solution to the pervasive problem of internal consistency estimation. Br J Psychol. 2014 Aug;105(3):399-412. doi: 10.1111/bjop.12046. Epub 2013 Aug 6. — View Citation

Elsesser, K., & Sartory, G. (1998). OUTCOME PREDICTORS OF BENZODIAZEPINE WITHDRAWAL. Behavioural and Cognitive Psychotherapy, 26(3), 209-217. https://doi.org/10.1017/S135246589800023X

Gabauer J. CE: Mitigating the Dangers of Polypharmacy in Community-Dwelling Older Adults. Am J Nurs. 2020 Feb;120(2):36-42. doi: 10.1097/01.NAJ.0000654312.14385.3d. — View Citation

Gehlert, S., & Ward, T. S. (2019). Theories of Health Behavior. In S. Gehlert & T. Browne (Éds.), Handbook of Health Social Work (1re éd., p. 143-163). Wiley. https://doi.org/10.1002/9781119420743.ch7

Gillespie R, Mullan J, Harrison L. Attitudes towards deprescribing and the influence of health literacy among older Australians. Prim Health Care Res Dev. 2019 Jun 20;20:e78. doi: 10.1017/S1463423618000919. — View Citation

Gillespie R, Mullan J, Harrison L. Managing medications: the role of informal caregivers of older adults and people living with dementia. A review of the literature. J Clin Nurs. 2014 Dec;23(23-24):3296-308. doi: 10.1111/jocn.12519. Epub 2013 Dec 20. — View Citation

Godin, G. (1991). L'éducation pour la santé : Les fondements psycho-sociaux de la définition des messages éducatifs. Sciences Sociales et Santé, 9(1), 67-94. https://doi.org/10.3406/sosan.1991.1185

Hanlon JT, Schmader KE. The Medication Appropriateness Index: A Clinimetric Measure. Psychother Psychosom. 2022;91(2):78-83. doi: 10.1159/000521699. Epub 2022 Feb 14. No abstract available. — View Citation

Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O'Neal L, McLeod L, Delacqua G, Delacqua F, Kirby J, Duda SN; REDCap Consortium. The REDCap consortium: Building an international community of software platform partners. J Biomed Inform. 2019 Jul;95:103208. doi: 10.1016/j.jbi.2019.103208. Epub 2019 May 9. — View Citation

Hinkin, T. R. (1998). A Brief Tutorial on the Development of Measures for Use in Survey Questionnaires. Organizational Research Methods, 1(1), 104-121. https://doi.org/10.1177/109442819800100106

Horne, R., Weinman, J., & Hankins, M. (1999). The Beliefs About Medicines Questionnaire : The Development and Evaluation of a New Method for Assessing the Cognitive Representation of Medication. Psychology & Health, 14(1), 1. https://doi.org/10.1080/08870449908407311

Koo TK, Li MY. A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research. J Chiropr Med. 2016 Jun;15(2):155-63. doi: 10.1016/j.jcm.2016.02.012. Epub 2016 Mar 31. Erratum In: J Chiropr Med. 2017 Dec;16(4):346. — View Citation

Lachman ME. Locus of control in aging research: a case for multidimensional and domain-specific assessment. Psychol Aging. 1986 Mar;1(1):34-40. doi: 10.1037//0882-7974.1.1.34. — View Citation

Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977 Mar;33(1):159-74. — View Citation

Linsky A, Simon SR, Bokhour B. Patient perceptions of proactive medication discontinuation. Patient Educ Couns. 2015 Feb;98(2):220-5. doi: 10.1016/j.pec.2014.11.010. Epub 2014 Nov 20. — View Citation

Martin P, Tamblyn R, Ahmed S, Tannenbaum C. A drug education tool developed for older adults changes knowledge, beliefs and risk perceptions about inappropriate benzodiazepine prescriptions in the elderly. Patient Educ Couns. 2013 Jul;92(1):81-7. doi: 10.1016/j.pec.2013.02.016. Epub 2013 Mar 29. — View Citation

McCoach, D. B., Gable, R. K., & Madura, J. P. (2013). Instrument Development in the Affective Domain : School and Corporate Applications. Springer. https://doi.org/10.1007/978-1-4614-7135-6

McDonald, R. P. (1999). Test Theory : A Unified Treatment. Psychology Press. https://doi.org/10.4324/9781410601087

Muhlack DC, Hoppe LK, Weberpals J, Brenner H, Schottker B. The Association of Potentially Inappropriate Medication at Older Age With Cardiovascular Events and Overall Mortality: A Systematic Review and Meta-Analysis of Cohort Studies. J Am Med Dir Assoc. 2017 Mar 1;18(3):211-220. doi: 10.1016/j.jamda.2016.11.025. Epub 2017 Jan 26. — View Citation

O'Donnell LK, Ibrahim K. Polypharmacy and deprescribing: challenging the old and embracing the new. BMC Geriatr. 2022 Sep 7;22(1):734. doi: 10.1186/s12877-022-03408-6. No abstract available. Erratum In: BMC Geriatr. 2022 Oct 3;22(1):777. — View Citation

Oktora MP, Edwina AE, Denig P. Differences in Older Patients' Attitudes Toward Deprescribing at Contextual and Individual Level. Front Public Health. 2022 Feb 11;10:795043. doi: 10.3389/fpubh.2022.795043. eCollection 2022. — View Citation

Olsson IN, Runnamo R, Engfeldt P. Medication quality and quality of life in the elderly, a cohort study. Health Qual Life Outcomes. 2011 Nov 3;9:95. doi: 10.1186/1477-7525-9-95. — View Citation

Page AT, Clifford RM, Potter K, Schwartz D, Etherton-Beer CD. The feasibility and effect of deprescribing in older adults on mortality and health: a systematic review and meta-analysis. Br J Clin Pharmacol. 2016 Sep;82(3):583-623. doi: 10.1111/bcp.12975. Epub 2016 Jun 13. — View Citation

Parekh N, Ali K, Davies K, Rajkumar C. Can supporting health literacy reduce medication-related harm in older adults? Ther Adv Drug Saf. 2018 Mar;9(3):167-170. doi: 10.1177/2042098618754482. Epub 2018 Feb 9. No abstract available. — View Citation

Parker G, Shahid N, Rappon T, Kastner M, Born K, Berta W. Using theories and frameworks to understand how to reduce low-value healthcare: a scoping review. Implement Sci. 2022 Jan 20;17(1):6. doi: 10.1186/s13012-021-01177-1. — View Citation

Pazan F, Wehling M. Polypharmacy in older adults: a narrative review of definitions, epidemiology and consequences. Eur Geriatr Med. 2021 Jun;12(3):443-452. doi: 10.1007/s41999-021-00479-3. Epub 2021 Mar 10. — View Citation

Pelikan JM, Link T, Strassmayr C, Waldherr K, Alfers T, Boggild H, Griebler R, Lopatina M, Miksova D, Nielsen MG, Peer S, Vrdelja M; HLS19 Consortium of the WHO Action Network M-POHL. Measuring Comprehensive, General Health Literacy in the General Adult Population: The Development and Validation of the HLS19-Q12 Instrument in Seventeen Countries. Int J Environ Res Public Health. 2022 Oct 29;19(21):14129. doi: 10.3390/ijerph192114129. — View Citation

Petein C, Spinewine A, Laroche ML, Niquille A, Henrard S. Adaptation and validation of the revised Patients' Attitudes towards Deprescribing (rPATD) questionnaire for benzodiazepine receptor agonists. Res Social Adm Pharm. 2023 Sep;19(9):1278-1285. doi: 10.1016/j.sapharm.2023.05.010. Epub 2023 Jun 8. — View Citation

Prochaska JO, DiClemente CC. Stages and processes of self-change of smoking: toward an integrative model of change. J Consult Clin Psychol. 1983 Jun;51(3):390-5. doi: 10.1037//0022-006x.51.3.390. No abstract available. — View Citation

Prochaska JO, Velicer WF. The transtheoretical model of health behavior change. Am J Health Promot. 1997 Sep-Oct;12(1):38-48. doi: 10.4278/0890-1171-12.1.38. — View Citation

Reeve E, Low LF, Shakib S, Hilmer SN. Development and Validation of the Revised Patients' Attitudes Towards Deprescribing (rPATD) Questionnaire: Versions for Older Adults and Caregivers. Drugs Aging. 2016 Dec;33(12):913-928. doi: 10.1007/s40266-016-0410-1. — View Citation

Reeve E, Shakib S, Hendrix I, Roberts MS, Wiese MD. Development and validation of the patients' attitudes towards deprescribing (PATD) questionnaire. Int J Clin Pharm. 2013 Feb;35(1):51-6. doi: 10.1007/s11096-012-9704-5. Epub 2012 Oct 9. — View Citation

Reeve E, To J, Hendrix I, Shakib S, Roberts MS, Wiese MD. Patient barriers to and enablers of deprescribing: a systematic review. Drugs Aging. 2013 Oct;30(10):793-807. doi: 10.1007/s40266-013-0106-8. — View Citation

Reeve E, Wolff JL, Skehan M, Bayliss EA, Hilmer SN, Boyd CM. Assessment of Attitudes Toward Deprescribing in Older Medicare Beneficiaries in the United States. JAMA Intern Med. 2018 Dec 1;178(12):1673-1680. doi: 10.1001/jamainternmed.2018.4720. — View Citation

Reeve J, Maden M, Hill R, Turk A, Mahtani K, Wong G, Lasserson D, Krska J, Mangin D, Byng R, Wallace E, Ranson E. Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis. Health Technol Assess. 2022 Jul;26(32):1-148. doi: 10.3310/AAFO2475. — View Citation

Rogers RW. A Protection Motivation Theory of Fear Appeals and Attitude Change1. J Psychol. 1975 Sep;91(1):93-114. doi: 10.1080/00223980.1975.9915803. — View Citation

Roux B, Rakheja B, Sirois C, Niquille A, Petein C, Ouellet N, Spinewine A, Sibille FX, Laroche ML. Attitudes and beliefs of older adults and caregivers towards deprescribing in French-speaking countries: a multicenter cross-sectional study. Eur J Clin Pharmacol. 2022 Oct;78(10):1633-1646. doi: 10.1007/s00228-022-03368-1. Epub 2022 Jul 27. — View Citation

Scott S, Wright DJ, Bhattacharya D. The role of behavioural science in changing deprescribing practice. Br J Clin Pharmacol. 2021 Jan;87(1):39-41. doi: 10.1111/bcp.14595. Epub 2020 Nov 5. No abstract available. — View Citation

Seewoodharry M, Khunti K, Davies MJ, Gillies C, Seidu S. Attitudes of older adults and their carers towards de-prescribing: A systematic review. Diabet Med. 2022 Jul;39(7):e14801. doi: 10.1111/dme.14801. Epub 2022 Feb 15. — View Citation

Spinewine A, Schmader KE, Barber N, Hughes C, Lapane KL, Swine C, Hanlon JT. Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet. 2007 Jul 14;370(9582):173-184. doi: 10.1016/S0140-6736(07)61091-5. — View Citation

Steinman MA. Polypharmacy-Time to Get Beyond Numbers. JAMA Intern Med. 2016 Apr;176(4):482-3. doi: 10.1001/jamainternmed.2015.8597. No abstract available. — View Citation

Strauss ME, Smith GT. Construct validity: advances in theory and methodology. Annu Rev Clin Psychol. 2009;5:1-25. doi: 10.1146/annurev.clinpsy.032408.153639. — View Citation

Trizano-Hermosilla I, Alvarado JM. Best Alternatives to Cronbach's Alpha Reliability in Realistic Conditions: Congeneric and Asymmetrical Measurements. Front Psychol. 2016 May 26;7:769. doi: 10.3389/fpsyg.2016.00769. eCollection 2016. — View Citation

Tsang S, Royse CF, Terkawi AS. Guidelines for developing, translating, and validating a questionnaire in perioperative and pain medicine. Saudi J Anaesth. 2017 May;11(Suppl 1):S80-S89. doi: 10.4103/sja.SJA_203_17. — View Citation

Turner JP, Martin P, Zhang YZ, Tannenbaum C. Patients beliefs and attitudes towards deprescribing: Can deprescribing success be predicted? Res Social Adm Pharm. 2020 Apr;16(4):599-604. doi: 10.1016/j.sapharm.2019.07.007. Epub 2019 Jul 10. — View Citation

Wallston KA, Wallston BS, DeVellis R. Development of the Multidimensional Health Locus of Control (MHLC) Scales. Health Educ Monogr. 1978 Spring;6(2):160-70. doi: 10.1177/109019817800600107. — View Citation

Weir KR, Ailabouni NJ, Schneider CR, Hilmer SN, Reeve E. Consumer Attitudes Towards Deprescribing: A Systematic Review and Meta-Analysis. J Gerontol A Biol Sci Med Sci. 2022 May 5;77(5):1020-1034. doi: 10.1093/gerona/glab222. — View Citation

Wolff JL, Boyd CM. A Look at Person- and Family-Centered Care Among Older Adults: Results from a National Survey [corrected]. J Gen Intern Med. 2015 Oct;30(10):1497-504. doi: 10.1007/s11606-015-3359-6. Epub 2015 May 2. Erratum In: J Gen Intern Med. 2015 Oct;30(10):1567. — View Citation

Yong, A. G., & Pearce, S. (2013). A Beginner's Guide to Factor Analysis : Focusing on Exploratory Factor Analysis.

* Note: There are 59 references in all — Click here to view all references

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Validity and reliability of the measurement tool - HBQtD	Questionnaire administration (HBQtD) for psychometric analyse	Throughout the entire study, approximately during 9 months
Primary	Correlation between deprescribing intention and behavior and deprescribing determinants using HBQtD questionnaire	Questionnaire administration (HBQtD) and regression analysis will be performed	Throughout the entire study, approximately during 9 months
Secondary	Moderating effect of health literacy using HLS19_Q12	HLS19_Q12 questionnaire administration and regression analysis will be performed	Throughout the entire study, approximately during 9 months
Secondary	Moderating effect of locus of control using Multidimensional Health locus of control scale (MHLC)	MHLC scale administration and regression analysis will be performed	Throughout the entire study, approximately during 9 months